{"id":17667,"date":"2022-11-02T01:03:47","date_gmt":"2022-11-02T00:03:47","guid":{"rendered":"http:\/\/www.infokuryr.cz\/n\/?p=17667"},"modified":"2022-11-01T17:04:57","modified_gmt":"2022-11-01T16:04:57","slug":"dve-studie-z-columbie-a-harvardu-ukazuji-ze-nove-omikronove-boostery-jsou-stejne-neucinne-jako-predchozi-injekce-covid","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2022\/11\/02\/dve-studie-z-columbie-a-harvardu-ukazuji-ze-nove-omikronove-boostery-jsou-stejne-neucinne-jako-predchozi-injekce-covid\/","title":{"rendered":"Dv\u011b studie z Columbie a Harvardu ukazuj\u00ed, \u017ee nov\u00e9 omikronov\u00e9 boostery jsou stejn\u011b ne\u00fa\u010dinn\u00e9 jako p\u0159edchoz\u00ed injekce Covid"},"content":{"rendered":"
<\/div>\n

FDA \u0159\u00edk\u00e1, \u017ee studie je p\u0159\u00edli\u0161 mal\u00e1 na to, aby bylo mo\u017en\u00e9 vyvodit z\u00e1v\u011bry<\/span><\/strong><\/span><\/h1>\n
\n
\n

V lo\u0148sk\u00e9m roce t\u00fdm CDC pro reakci na COVID-19 vydal v p\u00e1tek t\u00fddenn\u00ed zpr\u00e1vu, v n\u00ed\u017e se uv\u00e1d\u00ed, \u017ee naprost\u00e1 v\u011bt\u0161ina pacient\u016f infikovan\u00fdch omikronovou variantou ve Spojen\u00fdch st\u00e1tech dosud byli pln\u011b o\u010dkovan\u00ed jedinci.<\/span><\/p>\n

Feder\u00e1ln\u00ed vl\u00e1da a sd\u011blovac\u00ed prost\u0159edky st\u00e1le lp\u00ed na zmen\u0161uj\u00edc\u00ed se men\u0161in\u011b Ameri\u010dan\u016f, kte\u0159\u00ed se st\u00e1le ob\u00e1vaj\u00ed \u201epandemie\u201c.<\/span><\/p>\n

Aktualizovan\u00e9 booster injekce Omicron z\u00edskaly povolen\u00ed k nouzov\u00e9mu pou\u017eit\u00ed a porota CDC se rozhodla doporu\u010dit injekce pro d\u011bti ve v\u011bku 5 a\u017e 11 let a osoby star\u0161\u00ed 12 let.<\/span><\/p>\n

Nov\u00e1 vakc\u00edna je \u00fadajn\u011b bivalentn\u00ed, co\u017e znamen\u00e1, \u017ee obsahuje dv\u011b slo\u017eky mRNA (messenger RNA) koronaviru.\u00a0Polovina vakc\u00edny je nam\u00ed\u0159ena proti p\u016fvodn\u00edmu kmeni, druh\u00e1 polovina proti subvariant\u00e1m BA.4 a BA.5 omicron.<\/span><\/p>\n

Tyto nov\u00e9 posilova\u010de COVID nebyly testov\u00e1ny na lidech, ale pouze na my\u0161\u00edch!<\/strong><\/span><\/p>\n

\u201eJak se d\u011bti vracej\u00ed do \u0161koly a lid\u00e9 obnovuj\u00ed sv\u00e9 p\u0159edpandemick\u00e9 chov\u00e1n\u00ed a aktivity, zvy\u0161uje se riziko vystaven\u00ed viru COVID-19.\u00a0O\u010dkov\u00e1n\u00ed z\u016fst\u00e1v\u00e1 nej\u00fa\u010dinn\u011bj\u0161\u00edm opat\u0159en\u00edm k prevenci v\u00e1\u017en\u00fdch n\u00e1sledk\u016f COVID-19, v\u010detn\u011b hospitalizac\u00ed a \u00famrt\u00ed,\u201c \u0159ekl Dr.\u00a0Peter Marks, Ph.D.<\/span><\/p>\n

\u201eA\u010dkoli je COVID-19 u d\u011bt\u00ed obvykle m\u00e9n\u011b z\u00e1va\u017en\u00fd ne\u017e u dosp\u011bl\u00fdch, b\u011bhem r\u016fzn\u00fdch vln COVID-19 onemocn\u011blo a bylo hospitalizov\u00e1no v\u00edce d\u011bt\u00ed.\u00a0Dlouhodob\u00e9 \u00fa\u010dinky se mohou objevit i u d\u011bt\u00ed, a to i po p\u016fvodn\u011b m\u00edrn\u00e9m onemocn\u011bn\u00ed.\u00a0Vyz\u00fdv\u00e1me rodi\u010de, aby zv\u00e1\u017eili z\u00e1kladn\u00ed o\u010dkov\u00e1n\u00ed d\u011bt\u00ed a v p\u0159\u00edpad\u011b pot\u0159eby podstoupili p\u0159eo\u010dkov\u00e1n\u00ed,\u201c dodal.<\/span><\/p>\n

Nyn\u00ed dv\u011b nez\u00e1visl\u00e9 studie v\u011bdc\u016f z Kolumbijsk\u00e9 univerzity v New Yorku a Harvardsk\u00e9 univerzity zjistily, \u017ee nov\u00e9 posilovac\u00ed vakc\u00edny nevyvol\u00e1vaj\u00ed u lid\u00ed lep\u0161\u00ed protil\u00e1tkovou odpov\u011b\u010f na BA.5 ne\u017e vakc\u00edny prvn\u00ed generace, uv\u00e1d\u00ed NBC.<\/span><\/p>\n

Vzorky od 21 pacient\u016f ve studii Columbia a 18 lid\u00ed z Harvardsk\u00e9 studie, kte\u0159\u00ed dostali nov\u00e9 posilovac\u00ed vakc\u00edny, byly porovn\u00e1ny se vzorky od lid\u00ed, kte\u0159\u00ed dostali starou vakc\u00ednu jako \u010dtvrt\u00e9 o\u010dkov\u00e1n\u00ed.<\/span><\/p>\n

FDA v\u0161ak uvedl, \u017ee tyto dv\u011b studie byly \u201emal\u00e9 a podl\u00e9haj\u00ed omezen\u00edm\u201c.<\/span><\/p>\n

\u201eJe d\u016fle\u017eit\u00e9 poznamenat, \u017ee tyto dv\u011b studie byly provedeny nez\u00e1visle.\u00a0Jsou to mal\u00e9 studie, ale jsou dv\u011b \u2013 nen\u00ed to jen n\u00e1hoda,\u201c \u0159ekl Dr.\u00a0Dan Barouch, hlavn\u00ed autor harvardsk\u00e9 studie.<\/span><\/p>\n

NBC\u00a0hl\u00e1s\u00ed<\/a>\u00a0:<\/strong><\/span><\/p>\n

V\u011bdci z Columbia University a Harvard University ve dvou nez\u00e1visl\u00fdch studi\u00edch zjistili, \u017ee nov\u00e9 boostery a star\u00e9 vakc\u00edny fungovaly v podstat\u011b stejn\u011b dob\u0159e proti Omicron BA.5, co\u017e vyvolalo pochybnosti, zda vakc\u00edny spln\u00ed vysok\u00e1 o\u010dek\u00e1v\u00e1n\u00ed Bidenovy administrativy.\u00a0Protil\u00e1tkov\u00e9 reakce byly m\u00edrn\u011b vy\u0161\u0161\u00ed u omikron\u016f, a\u010dkoli studie dosp\u011bly k z\u00e1v\u011bru, \u017ee rozd\u00edl nen\u00ed v\u00fdznamn\u00fd.<\/span><\/em><\/p>\n

Dr\u00a0Peter Marks, vedouc\u00ed divize vakc\u00edn FDA, \u0159ekl, \u017ee testy jsou mal\u00e9 a podl\u00e9haj\u00ed omezen\u00edm.\u00a0\u00dadaje z v\u011bt\u0161\u00edch, dob\u0159e kontrolovan\u00fdch studi\u00ed se o\u010dek\u00e1vaj\u00ed v bl\u00edzk\u00e9 budoucnosti, \u0159ekl.\u00a0Spole\u010dnosti Pfizer a Moderna prov\u00e1d\u011bj\u00ed klinick\u00e9 zkou\u0161ky nov\u00fdch posilovac\u00edch vakc\u00edn a o\u010dek\u00e1v\u00e1 se, \u017ee \u00fadaje ozn\u00e1m\u00ed koncem tohoto roku.<\/span><\/cite>Je d\u016fle\u017eit\u00e9 poznamenat, \u017ee i \u00fadaje z t\u011bchto po\u010d\u00e1te\u010dn\u00edch mal\u00fdch studi\u00ed nazna\u010duj\u00ed, \u017ee bivalentn\u00ed vakc\u00edny jsou obecn\u011b p\u0159inejmen\u0161\u00edm stejn\u011b dobr\u00e9 nebo lep\u0161\u00ed ne\u017e p\u016fvodn\u00ed vakc\u00edny, pokud jde o vyvol\u00e1n\u00ed imunitn\u00ed reakce, zejm\u00e9na na BA.4\/BA.5 a dal\u0161\u00ed nov\u011bj\u0161\u00ed varianty,\u201c uvedl Marks v prohl\u00e1\u0161en\u00ed.<\/span><\/em><\/p>\n

Dokonce i m\u00edrn\u00e9 zv\u00fd\u0161en\u00ed imunitn\u00ed reakce by mohlo m\u00edt pozitivn\u00ed d\u016fsledky pro ve\u0159ejn\u00e9 zdrav\u00ed, dodal.<\/span><\/cite>FDA nad\u00e1le vyz\u00fdv\u00e1 zp\u016fsobil\u00e9 jednotlivce, aby zv\u00e1\u017eili aktualizovanou vakc\u00ednu na ochranu p\u0159ed aktu\u00e1ln\u011b koluj\u00edc\u00edmi variantami Covid-19 a nadch\u00e1zej\u00edc\u00ed vlnou Covid-19,\u201c \u0159ekl Marks.<\/span><\/em><\/p>\n<\/div>\n<\/div>\n

\n
\n

ZDROJ<\/a><\/span><\/h3>\n

 <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FDA \u0159\u00edk\u00e1, \u017ee studie je p\u0159\u00edli\u0161 mal\u00e1 na to, aby bylo mo\u017en\u00e9 vyvodit z\u00e1v\u011bry V…<\/p>\n","protected":false},"author":2,"featured_media":5887,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[23,1088,213,839,651],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/17667"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=17667"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/17667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/5887"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=17667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=17667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=17667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}